| Company/Division name | Watchmaker Genomics |
| Parent company | Watchmaker Genomics |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2027 |
| City reshored to: | Boulder |
| State(s) reshored to: | CO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | reagents used in genomics and molecular diagnostic |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Infrastructure, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |
